Jan 22 (Reuters) - REMSleep Holdings Inc RMSL.PK :
* REMSLEEP HOLDINGS INC.'S DELTAWAVE MASK HAS RECEIVED
QUESTIONS
FROM FDA REGARDING 510K SUBMISSION (K233415)
* REMSLEEP HOLDINGS INC: AGENCY HAS DETERMINED THAT
ADDITIONAL
INFORMATION IS REQUIRED
* REMSLEEP HOLDINGS INC - AGENCY HAS ALSO REQUESTED
ADDITIONAL
SHELF-LIFE TESTING FOR DELTAWAVE PACKAGING
* REMSLEEP HOLDINGS INC - IN PROCESS OF INITIATING
ACCELERATED
SHELF-LIFE TESTING FOR DELTAWAVE PACKAGING
* REMSLEEP HOLDINGS INC - HAS APPLIED FOR A GOVERNMENT GRANT
TO
PERFORM CLINICAL TRIALS ONCE 510(K) SUBMISSION HAS BEEN APPROVED
* REMSLEEP HOLDINGS INC - HAS BEEN ALLOWED A NEW US PATENT
FOR
DELTAWAVE PRODUCT
* REMSLEEP: FDA HAS ASKED FOR ADDITIONAL INFORMATION ON
ADMINISTRATIVE INFORMATION, DEVICE DESCRIPTION, SUBSTANTIAL
EQUIVALENCE, LABELING, ETC
Source text for Eikon: urn:newsml:reuters.com:*:nGNX7jhktG
Further company coverage: RMSL.PK
((Reuters.Briefs@thomsonreuters.com;))